B Dubois1, J L Montastruc. Show Affiliations » 1. Fédération de Neurologie, INSERM U289, Hôpital Pitié-Salpêtrière, Paris.
Abstract
Entities: Chemical Disease
Mesh: See more » Antiparkinson Agents/adverse effectsAntiparkinson Agents/therapeutic useDrug Therapy, CombinationHumansLevodopa/adverse effectsLevodopa/therapeutic useParkinson Disease/drug therapyParkinson Disease/mortalityRisk FactorsSelegiline/adverse effectsSelegiline/therapeutic use
Substances: See more » Antiparkinson AgentsSelegilineLevodopa
Year: 1996 PMID: 8761616
Source DB: PubMed Journal: Rev Neurol (Paris) ISSN: 0035-3787 Impact factor: 2.607